Federal
Register Notices > Importers
>
Cambrex Charles City, Inc.
FR Doc E7-11915 [Federal Register: June 20, 2007 (Volume 72, Number 118)]
[Notices] [Page 34040] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr20jn07-132]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to Title
21 Code of Federal Regulations 1301.34(a), this is notice that on April
23, 2007, Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa
50616-3466, made application by letter to the Drug Enforcement Administration
(DEA) for registration as an importer of the basic classes of controlled
substances listed in schedules II:
Drug
|
Schedule
|
Thebaine (9333)
|
II
|
Raw Opium (9600)
|
II
|
Concentrate of Poppy Straw (9670)
|
II
|
The company plans to import the listed controlled substances for
manufacture of active pharmaceutical ingredients for sale to its customers.
No comments, objections, or requests for any hearings will be received on
any application for registration or re-registration to import crude opium,
poppy straw, concentrate of poppy straw, and coca leaves.
Any bulk manufacturer who is presently, or is applying to be, registered
with DEA to manufacture such basic classes of controlled substances listed in
schedule I or II, which fall under the authority of section 1002(a)(2)(B) of
the Act (21 U.S.C.
952(a)(2)(B)) may file comments or objections to the issuance of the
proposed registration and may, at the same time, file a written request for a
hearing on such application pursuant to 21
CFR 1301.43 and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections may be addressed, in quintuplicate, to the
Drug Enforcement Administration, Office of Diversion Control, Federal Register
Representative (ODL), Washington, DC 20537; or any being sent via express mail
should be sent to Drug Enforcement Administration, Office of Diversion
Control, Federal Register Representative (ODL), 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be filed no later than July 20, 2007.
This procedure is to be conducted simultaneously with and independent of
the procedures described in 21 CFR Sec. 1301.34(b), (c), (d), (e) and (f). As
noted in a previous notice published in the Federal Register on September 23,
1975, (40 FR 43745), all applicants for registration to import a basic class
of any controlled substances in schedule I or II are and will continue to be
required to demonstrate to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21
U.S.C. 958(a), 21
U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e) and (f) are satisfied.
Dated: June 7, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-11915 Filed 6-19-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|